Industry Outlook: Key Trends in Shaping the CDMO Industry in 2023

According to Hanns-Christian Mahler (Chief Enablement Officer of ten23), following are the top key trends shaping the CDMO industry in 2023:

Sustainability Drive

The pharmaceutical and CDMO sectors are compelled to reassess their operations, recognizing the environmental impact. Addressing emissions alone is insufficient; a comprehensive approach encompassing waste, water, and biodiversity is necessary to minimize ecological consequences.

Patient-Centric Treatment

Patient-led administration of intricate treatments, such as biologics, is on the rise. Patients self-administering their treatments reduces errors, enhances compliance, and enables home care.

This is particularly beneficial in cancer cases, improving quality of life and cost-effectiveness. The demand for devices facilitating self-administration is expected to grow.

Customized Expertise

CDMOs must specialize in developing, manufacturing, and testing drug/device combinations and customized packaging. This expertise is crucial to cater to the trend of patient-driven treatments.

In summary, the CDMO landscape should evolve towards sustainability, patient empowerment, specialized production, and adaptability to smaller batch manufacturing in response to emerging industry dynamics.

“3 key trends” with Hanns-Christian Mahler. Contract Pharma. (n.d.). https://www.contractpharma.com/contents/view_online-exclusives/2023-08-11/3-key-trends-with-hanns-christian-mahler/?